BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• FDA

  Coherex Medical, Inc. Announces CE Mark for the WaveCrest LAA Occlusion System

  September 3, 2013

   · 

  1 min read
• FDA

  SpineGuard Receives Regulatory Ninsho Approval to Sell its PediGuard® Platform in Japan

  September 3, 2013

   · 

  1 min read
• Drug Development

  Teva Pharmaceutical Industries Limited to Drop Depression Treatment After Phase 3 Trial Fails

  September 3, 2013

   · 

  6 min read
• Business

  Philips Healthcare, Johnson & Johnson Land U.S. Department of Defense Contracts Worth Up to $73 Million

  September 3, 2013

   · 

  1 min read
• BioCapital

  Incyte Corporation Release: New ‘“Voices of MPN” Initiative Unites, Connects and Supports Community Affected by Rare Blood Cancers: Myeloproliferative Neoplasms (MPNs)

  September 3, 2013

   · 

  1 min read
• Drug Development

  TetraPhase Pharmaceuticals Doses First Patient in Phase 3 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections

  September 3, 2013

   · 

  1 min read
• BioMidwest

  Mallinckrodt Inc. Continues Efforts to Fight Medicine Abuse With The Partnership® at Drugfree.org

  September 3, 2013

   · 

  1 min read
• Business

  Selcia Limited and Cantab Pharmaceuticals PLC Announce Drug Discovery Collaboration

  September 3, 2013

   · 

  3 min read
• Pharm Country

  Vybion, Inc.’s Huntington Drug Neutralizes Critical Disease Driver

  September 3, 2013

   · 

  1 min read
• Biotech Beach

  Amgen to Participate at Citi’s 8th Annual Biotech Conference

  September 3, 2013

   · 

  1 min read